NEW YORK (GenomeWeb News) – BGI-Shenzhen has extended its cash tender offer for Complete Genomics again, BGI announced late Friday.
The deal is now set to expire midnight EST, Feb. 1. It had been previously extended until midnight EST, Jan. 25.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.